HKSE - Delayed Quote • HKD Precision Tsugami (China) Corporation Limited (1651.HK) Follow 9.230 0.000 (0.00%) At close: April 26 at 3:34 PM GMT+8 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for 1651.HK 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations 10 Best Carfax Alternatives to Check Vehicle History Regulators Set to Seize Troubled Philadelphia Bank Republic First Exxon and Chevron Earnings Fall Back to Earth Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom Why Saia Stock Plunged Today Abbvie stock falls amid growing biosimilar competition Cava, IBD Stock Of The Day, Surges Past Buy Point As Restaurants Come In Hot AMC Entertainment Sees Flat Revenue in Despite Fewer Film Releases Exxon’s profits are falling, but CEO Darren Woods’ compensation rose last year—here’s how the oil giant rewards its top exec AMC Entertainment Holdings, Inc. Previews First Quarter 2024 Preliminary Results and Announces First Quarter 2024 Earnings Webcast These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
